Abstract: A recombinant hybrid protein, a nucleic acid molecule encoding the recombinant hybrid protein, a transgenic expression cassette containing the nucleic acid molecule, and a gene delivery system containing the transgenic expression cassettes that can be used for treating muscular dystrophy. The nucleic acid molecule, the transgenic expression cassette and the gene delivery system can stably express a therapeutic protein in muscle tissues, so that a good therapeutic effect on muscular dystrophy is realized.

Abstract: Provided are an injection device, an injection device without changing an original structure of a syringe, and a method for using the same. The injection device includes a barrel (1) with a flange (8) and a push rod (2) slidably connected in the barrel (1). One end of the push rod (2) is provided with a piston (3), and the other end is provided with a thumb rest (4). The push rod (2) or the barrel (1) is detachably connected with a stopping member (5), and the stopping member (5) is provided with a first stopping portion (51) and a second stopping portion (52) at different positions. A distance between the first stopping portion (51) and the second stopping portion (52) is a fixed distance.

Abstract: A monitoring system includes multiple redundant processes for gathering and archiving information. The processes are well adapted for use within a call center which has multiple agents for processing inbound/outbound calls. The information concerns the calling activity of the agents. One of the processes is designated as a primary process for providing archived information to clients. The other processes are redundant secondary processes which assume the role of the primary process upon failure of the primary process. Once a failed process is reinitiated, a data synchronization mechanism is used to reconcile data to ensure that each of the processes has current and up-to-date information.